Two shoulder replacement types compared for shoulder joint osteoarthritis
Compares pyrocarbon hemiarthroplasty with total shoulder replacement in people with glenohumeral osteoarthritis.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Registry title
- Pyrocarbon Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis
- Status
- Enrolling by invitation
- People taking part
- 74 people, planned
- Started
- 3 Feb 2026
- Expected to end
- Feb 2040
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hemiarthroplasty with pyrocarbon
- Anatomic total shoulder arthroplasty
- Record updated
- 19 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 to 65 with shoulder joint arthritis (glenohumeral osteoarthritis) who need surgery. People are randomly put into one of two shoulder replacement types and followed for ten years.
- Age
- 40 to 65 years
- Sex
- All sexes
- Disease stage
- Glenohumeral osteoarthritis that needs surgery. The surgeon must judge that either implant type is a reasonable choice. People must be in good general health.
- Earlier treatment
- People who regularly used narcotic painkillers within three months of surgery cannot join. People with long-term use of steroid tablets (oral corticosteroids) cannot join.
Main reasons for not taking part
- Walch Type C or D glenoid (shoulder socket shape), or a socket that cannot be rebuilt with the study parts
- Severe socket deformity: retroversion >30 o, or retroversion >20 o with inclination > 10 o
- Full-thickness rotator cuff tear
- Known allergy to parts of the study implants
- Current or past drug or alcohol abuse, or a workers' compensation case
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Fluent in English language
- Willing to sign an informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Age 40 to 65 years
- In good general health as evidenced by medical history
- Surgical indication of glenohumeral osteoarthritis 7. In the opinion of the surgeon, there is clinical equipoise for the subject to be implanted with a humeral hemiarthroplasty with pyrocarbon or anatomic total shoulder arthroplasty
Who cannot take part
- History or current drug or alcohol abuse
- Known allergic reactions to components of the study product(s)
- History of consistent narcotic use within three months of surgery
- History of chronic oral corticosteroid use
- Presence of Walch Type C or D glenoid
- Presence of a glenoid that could not be reconstructed with the anatomic glenoid resurfacing components
- Presence of extreme preoperative glenoid deformity including uniplanar retroversion deformity >30 o or severe biplanar deformity (retroversion >20 o and inclination > 10 o)
- Workers' compensation case
- Presence of full-thickness rotator cuff tear
- In the surgeon's opinion, the subject will be non-compliant with the study protocol
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 65 years old?
Where in United States
- Washington UniversitySt Louis, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This is a multi-center study assessing postoperative outcomes associated with hemiarthroplasty with pyrocarbon (hPYC) versus anatomic total shoulder arthroplasty (aTSA). Once eligibility criteria is met, the subject will be randomized to one of the two study arms. Subjects will be followed for ten years. Clinical and patient-reported outcome measures (PROMs) will be assessed.
The 2 groups in the trial
- Hemiarthroplasty with pyrocarbonExisting treatment, for comparison
- Anatomic total shoulder arthroplastyExisting treatment, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: The Impact of Modern Implant Options
- Plain-language title
- Two shoulder replacement types compared for shoulder joint osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07226388, who can take part
- Record updated
- 19 February 2026